The artificial intelligence health care market is expected to grow by more than 500% from $29bn in 2024 to $187bn by 2030, and could bring much value to the pharma industry by streamlining drug discovery, clinical trials, and supply chain management, according to a report from global consulting firm Berkeley Research Group (BRG).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?